[mo_oauth_login]
Summary reportFARMATSEUT29 TÜ
Date of report 08.01.2025
FARMATSEUT29 TÜ
12503580 - Deleted (15.12.2016)
Founded in 11.07.2013
Fixed capital -
Former names
- TÜ Farmatseut29
keywords
- laenuühistud
- valdusfirmad
- valdusfirmade tegevus
FARMATSEUT29 TÜ
Scores and ratings
Reputation score
Credit Score
Deleted 0.01
Status 15.12.2016 Deleted 0.01
Open the reports you want to print
Employees and salaries
FARMATSEUT29 TÜ
Employee taxes and performance analysis?
Quarter | Labor taxes paid | Number of employees | Turnover Per Employee | Profit per employee |
---|---|---|---|---|
2016 IV | ...... | ...... | ...... | ...... |
2016 III | ...... | ...... | ...... | ...... |
2016 II | ...... | ...... | ...... | ...... |
2016 I | ...... | ...... | ...... | ...... |
2015 IV | ...... | ...... | ...... | ...... |
2015 III | ...... | ...... | ...... | ...... |
2015 II | ...... | ...... | ...... | ...... |
2015 I | ...... | ...... | ...... | ...... |
Deciders and beneficiaries
FARMATSEUT29 TÜ
Former decision-makers?
2020 II quarter
Turnover: 7 929 613 €
Employees:
Average salary: 53 120 €
PHARMA GROUP OÜ
......
139 followers
FARMATSEUT29 TÜ
History of right of representation?
Field
Finance
Business age
3y
Beneficial country:
et
2013
2015
2016
2018
2020
2022
2023
2025
2013
2014
2015
2016
2017
2018
2020
2021
2022
2023
2024
2025
FARMATSEUT29 TÜ
Owners?
Former owners
FARMATSEUT29 TÜ
Other related parties?
Former other persons
Name | Credit Score | Part | Beginning |
---|---|---|---|
...... | ...... |
Finances and assets
FARMATSEUT29 TÜ
Taxes paid and estimated average salariesFARMATSEUT29 TÜ
Financial indicators and prognosisFARMATSEUT29 TÜ
Financial raiting: "SATISFACTORY" (2015)2015
LIQUIDITY
?
Net Working capital
...
Short-term debt coverage ratio
...
USE OF LOAN CAPITAL
?
Turnover ratio of fixed assets (X)
...
EFFECTIVENESS
?
Debt to assets ratio (X)
...
Capitalisation multiplier (X)
...
PROFITABILITY
?
Sales revenues (%)
...
Total asset revenues (%)
...
Equity revenues (%)
...
Unsatisfactory
1
2
3
4
5
Very good
FARMATSEUT29 TÜ
Annual reportsLiabilities and debts
FARMATSEUT29 TÜ
Credit score history and prognosisRecommended credit limit
... €
Recommended payment term
......
Business risk classes:
Trustworthy Neutral Borderline Problematic Risky
FARMATSEUT29 TÜ
Reports and assets-liabilities overview 15.12.2016?
Annual reports: ......
Annual reports: ......
Tax declarations:......
Assets to cover liabilities (short-term)
Assets: ...... €1 EURO of assets to cover short-term debt obligations: ...... €
Liabilities: ...... €Net Working capital: ...... €
FARMATSEUT29 TÜ
Claims history?
1 month
6 months
Year
5 years
MAX
Debt claims as of ......
Total debt claims: ...... €
Latest events
...... | ...... |
FARMATSEUT29 TÜ
Bailiff's enforcement proceedings as of 15.12.2016?
Bailiff's enforcement proceedings MISSING
FARMATSEUT29 TÜ
Regulations of the Payment Order Department as of 15.12.2016?
Regulations of the Payment Order Department MISSING
FARMATSEUT29 TÜ
Court orders in the register as of 15.12.2016?
Court order MISSING
FARMATSEUT29 TÜ
Decisions of the Consumer Disputes Committee as of 15.12.2016?
Consumer disputes MISSING
FARMATSEUT29 TÜ
Court hearings as of 15.12.2016?
Court hearings MISSING
FARMATSEUT29 TÜ
Rulings as of 15.12.2016?
Court settlemets MISSING
FARMATSEUT29 TÜ
Notices and announcements as of 15.12.2016?
Announcements MISSING
Marketing
Business network
FARMATSEUT29 TÜ
Business networkCREDIT RISK CLASSES
Deleted
Trustworthy
Neutral
Borderline
Problematic
Risky
Historical connection
Active connection
amount of turnover
amount of debt
Extension of networks
The network is visible with reduced links
Expand threads if desired
Sign in
To expand your connections, log in to the "Networks" environment
Beneficiaries network
FARMATSEUT29 TÜ
Networks - Beneficiaries The network is visible with reduced links
Expand threads if desired
Sign in
To expand your connections, log in to the "Networks" environment
Monitoring events
Filter
Dropdown
Dropdown
Neutral
Positive
Negative
No monitoring events found.
Failed to load monitoring events.